Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease

NCT06623110 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

High-Risk Oral Precancerous Disease

Interventions

BIOLOGICAL: RP2 Injection

Sponsor

Glenn J. Hanna

Collaborators

[object Object]